Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04233944 · ClinicalTrials.gov registry record
Uganda Birth Cohort Study
A clinical trial, sponsored by Tufts University.
- Terminated
- Registry status
- 5,044
- Enrollment target
NCT04233944: Clinical Trial study, sponsored by Tufts University.
NCT04233944 is a clinical trial that was terminated before completion, run by Tufts University. The registered enrollment target is 5,044 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04233944 was terminated before completion, sponsored by Tufts University.
- TERMINATED
- Registry status
- 5,044 participants
- Enrollment target
Study Summary
The UBC was a USAID-funded longitudinal prospective cohort study of pregnant women (n= 5030) aged 15-49 years from rural North and South-Western regions of Uganda, conducted between 2014 and 2016. The aim of the UBC study was to observationally follow pregnant women and their newborns until 2 years of age and compare changes over time in communities that were part of an ongoing USAID project called the Community Connector (CC) compared to those communities that were not included in the Community Connector project.
Primary Outcome
Percent of infants with a height-for-age less than -2 standard deviations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,044 participants |
| Start Date | 2014-11-15 |
| Est. Completion | 2016-11-04 |
Why NCT04233944 stopped before completion
NCT04233944 is an observational study that tracks outcomes without assigning an intervention. Its 5,044 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04233944 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04233944 about?
NCT04233944 is a clinical study titled "Uganda Birth Cohort Study". The UBC was a USAID-funded longitudinal prospective cohort study of pregnant women (n= 5030) aged 15-49 years from rural North and South-Western regions of Uganda, conducted between 2014 and 2016. The aim of the UBC study was to observationally follow pregnant women and their newborns until 2 years ...
What is the current status of trial NCT04233944?
This trial is currently terminated. The enrollment target is 5,044 participants. The study started on 2014-11-15. Estimated completion is 2016-11-04.
Who is sponsoring clinical trial NCT04233944?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07037459 · 5,056 participants · Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- NCT06292078 · 5,076 participants · NA
Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
- NCT04743362 · 5,010 participants
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI